PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Apr-2024 Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed Kinarus Therapeutics Holding AG
26-Apr-2024 STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 STRATEC SE
25-Apr-2024 Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next-Gen CRC Test Mainz BioMed N.V.
25-Apr-2024 1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project (news with additional features) SYNBIOTIC SE
25-Apr-2024 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma
25-Apr-2024 BIAL appoints Pierluigi Antonelli as Non-Executive Board Member BIAL
25-Apr-2024 Asklepios Group: Asklepios shows resilience in 2023 financial year Asklepios Kliniken
25-Apr-2024 MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros. MPH Health Care AG
25-Apr-2024 Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios Marinomed Biotech AG
25-Apr-2024 Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024 Drägerwerk AG & Co. KGaA
25-Apr-2024 Formycon reports audited annual results for the financial year 2023 – Looking back on a successful operative year and exceeded guidance Formycon AG
25-Apr-2024 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG
24-Apr-2024 Biophytis Announces Transfer of ADSs to OTC Market Biophytis
24-Apr-2024 MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting MorphoSys AG
24-Apr-2024 CDMO Live: New Event Launched To Accelerate, De-Carbonise and Optimise Contract Manufacturing PharmaSource / Life Science Networks
24-Apr-2024 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update CureVac
24-Apr-2024 CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK CureVac
24-Apr-2024 CureVac Appoints Thaminda Ramanayake as New Chief Business Officer CureVac
24-Apr-2024 BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer BeiGene
24-Apr-2024 Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices Chiesi Group